Exagen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.51

+0.15 (+4.46%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,350.7% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $3.51

Current
$3.51

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

967.8%

Low target

Base Case

$50.92

+1,350.7%

Avg target

Bull Case

$70.07

+1,896.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$49.66

-92.9% from high

52-Week Low

$28.58

+-87.7% from low

Target vs 52W High

$50.92

+2.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%